A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine
Article first published online: 21 NOV 2012
© 2012 John Wiley & Sons Ltd
Influenza and Other Respiratory Viruses
Volume 7, Issue 6, pages 1181–1193, November 2013
How to Cite
Svindland, S. C., Pedersen, G. K., Pathirana, R. D., Bredholt, G., Nøstbakken, J. K., Jul-Larsen, Å., Guzmán, C. A., Montomoli, E., Lapini, G., Piccirella, S., Jabbal-Gill, I., Hinchcliffe, M. and Cox, R. J. (2013), A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine. Influenza and Other Respiratory Viruses, 7: 1181–1193. doi: 10.1111/irv.12056
- Issue published online: 5 NOV 2013
- Article first published online: 21 NOV 2012
- Accepted 14 September 2012. Published Online 19 November 2012.
- Norwegian Research Counsel Globvac. Grant Number: 185441
Figure S1. The weight of the mice after influenza H5N1 vaccination.
|irv12056_sm_FigS1.docx||200K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.